Advisors Capital Management, LLC Abcam PLC Transaction History

Advisors Capital Management, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	BUY	$12.62 - $24.47 $4,429 - $8,588	351 Added 0.17%	209,849 $5.14 Million
Q1 2023 May 04, 2023	BUY	$12.98 - $17.1 $28,062 - $36,970	2,162 Added 1.04%	209,498 $2.82 Million
Q4 2022 Feb 13, 2023	BUY	$13.92 - $17.0 $1.99 Million - $2.43 Million	143,102 Added 222.78%	207,336 $3.23 Million
Q3 2022 Nov 16, 2022	BUY	$13.36 - $16.75 $31,289 - $39,228	2,342 Added 3.78%	64,234 $1.08 Million
Q2 2022 Aug 12, 2022	SELL	$12.69 - $19.25 $38,691 - $58,693	-3,049 Reduced 4.7%	61,892 $895,000
Q1 2022 May 10, 2022	BUY	$15.5 - $23.89 $42,067 - $64,837	2,714 Added 4.36%	64,941 $1.19 Million
Q4 2021 Feb 14, 2022	BUY	$20.04 - $23.84 $126,412 - $150,382	6,308 Added 11.28%	62,227 $1.47 Million
Q3 2021 Nov 12, 2021	SELL	$17.38 - $21.54 $103,828 - $128,679	-5,974 Reduced 9.65%	55,919 $1.13 Million
Q2 2021 Aug 02, 2021	BUY	$18.47 - $22.11 $216,062 - $258,642	11,698 Added 23.31%	61,893 $1.18 Million
Q1 2021 May 12, 2021	BUY	$19.22 - $24.3 $964,747 - $1.22 Million	50,195 New	50,195 $964,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisors Capital Management, LLC with notifications on news.